THE DARK REPORT
21806 Briarcliff Dr.
Spicewood, TX 78669
FOR IMMEDIATE RELEASE
Media Contact: Liz Carey
AUSTIN, Texas (July 1, 2020) – Current events have highlighted the critical role of the clinical laboratory as the primary source of diagnostic information. And with legislation such as PAMA reducing reimbursement, labs must now determine the best direction in defining their role and its value to the hospital or health system.
“Unfortunately, this critical role in determining diagnoses and treatments also makes the lab vulnerable to abuse,” said Robert L. Michel, Editor-In-Chief of The Dark Report. “Studies estimate that from 10% to 25% of all hospital-performed laboratory tests in the inpatient setting are not indicated. What’s more, an increasingly complex and expanding set of diagnostic test options necessitates heightened awareness in order to choose the right test at the right time,” continued Michel.
To give laboratory management professionals frontline perspective and commentary from experts and physicians on the application and value of decision support in the lab, Robert L. Michel is offering a recently published free White Paper entitled, “Case Studies in Clinical Laboratory Test Stewardship: The Financial and Clinical Impact of Clinical Decision Support in Hospital Laboratories.” Published by Dark Daily in partnership with Mayo Clinic Laboratories and NDSC, a Change Healthcare company, this paper is available as a PDF download.
This White Paper provides the following valuable insights:
- Defining the lab’s specific stewardship goals and measuring progress toward them using robust analytics tools in order to take control of test utilization
- Clinically grounded guidelines that can be applied in the lab to help address the problem of too much data and information for providers to consume
- How one hospital identified that B-type natriuretic peptide (BNP) was frequently over-ordered on their wards, and the steps they took that led to a decline of 33%-43% in inappropriate BNP orders
- Why looking at data at the facility level, then the department level, then the provider level is of greatest benefit to the lab
Members of the laboratory’s leadership team should download this exclusive White Paper, third in a three-part series, to learn what they need to know to maximize efficiency, increase profitability, and decrease costs by leveraging a Clinical Decision Support System, in order to identify overutilization and inappropriate lab testing as areas to target for process improvement and cost savings. Click here for part one of the White Paper series and here for part two.
Interested lab professionals should also watch for details on an upcoming Dark Daily webinar based on this White Paper series, featuring participants from Riverside Medical Center, Carle Health, and Mayo Clinic who will be discussing the latest on implementing clinical decision support and its value in managing workflow and improving mis-utilization, especially during times of reduced resources.
“Case Studies in Clinical Laboratory Test Stewardship: The Financial and Clinical Impact of Clinical Decision Support in Hospital Laboratories” is part of the Dark Daily growing library of White Papers and other information resources tailored specifically to the needs of laboratory administrators, lab managers, pathologists, and lab industry consultants.
About The Dark Intelligence Group
Established in 1995, The Dark Intelligence Group is the leading source of exclusive business intelligence for laboratory CEOs, COOs, CFOs, Pathologists and senior industry executives. It is widely recognized by leaders in laboratory medicine and diagnostics. The Dark Intelligence Group produces the famous Executive War College on Laboratory and Pathology Management every spring, which showcases innovations by the nation’s and globe’s leading laboratory organizations., and Dark Daily — a free e-briefing intelligence service, read worldwide by thought leaders in laboratory and pathology management. Other well-known conferences conducted by TDIG are Lab Quality Confab (on the use of Lean and Six Sigma methods in labs and hospitals), Executive Edge bi-annually in Canada, and The Business of Pathology bi-annually in Australia.